Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Janux Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −2 vs. Q1 2022
- Shares held
- 28.9M
- +525.5K (+1.9%) vs. Q1 2022
- Total value
- $353.0M
- −$54.1M (−13.3%) vs. Q1 2022
- New holders
- 3
- 15 more added
- Sold out
- 5
- 15 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,670,644 | $105.9M | 2.82% | 00.0% | Unchanged |
| FMR LLC | 5,825,704 | $71.1M | 0.01% | +148,778+2.6% | Added |
| OrbiMed Advisors LLC | 2,836,386 | $34.6M | 0.67% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,127,797 | $26.0M | 0.02% | −211,349−9.0% | Reduced |
| Citadel Advisors LLC | 1,853,432 | $22.6M | 0.03% | 00.0% | Unchanged |
| BVF Inc | 1,470,334 | $18.0M | 0.87% | +327,994+28.7% | Added |
| EcoR1 Capital, LLC | 1,421,319 | $17.4M | 0.60% | 00.0% | Unchanged |
| BlackRock Inc. | 1,208,354 | $14.8M | 0.00% | +46,633+4.0% | Added |
| Vanguard Group Inc | 649,640 | $7.93M | 0.00% | +83,661+14.8% | Added |
| 5AM Venture Management, LLC | 446,266 | $5.45M | 1.35% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 400,000 | $4.88M | 0.01% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 360,414 | $4.40M | 1.18% | −51,457−12.5% | Reduced |
| Woodline Partners LP | 286,383 | $3.50M | 0.06% | +8,060+2.9% | Added |
| Geode Capital Management, LLC | 283,620 | $3.46M | 0.00% | +8,389+3.0% | Added |
| State Street Corp | 264,022 | $3.22M | 0.00% | +22,024+9.1% | Added |
| Cerity Partners LLC | 150,933 | $1.84M | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 133,157 | $1.63M | 0.00% | −7,090−5.1% | Reduced |
| JPMorgan Chase & Co | 103,478 | $1.26M | 0.00% | +85,552+477.3% | Added |
| Nuveen Asset Management, LLC | 74,873 | $915.0K | 0.00% | +49,213+191.8% | Added |
| DekaBank Deutsche Girozentrale | 49,500 | $566.0K | 0.00% | +49,500 | New |
| Charles Schwab Investment Management Inc | 42,510 | $520.0K | 0.00% | −1,890−4.3% | Reduced |
| Bank of New York Mellon Corp | 42,386 | $517.0K | 0.00% | −3,615−7.9% | Reduced |
| Parkwood LLC | 33,750 | $412.0K | 0.08% | +5,492+19.4% | Added |
| Wells Fargo & Company | 29,640 | $362.0K | 0.00% | +24,898+525.1% | Added |
| Morgan Stanley | 27,733 | $337.0K | 0.00% | −100.0% | Reduced |
| Bank of America Corp | 25,518 | $312.0K | 0.00% | −15,641−38.0% | Reduced |
| Rhumbline Advisers | 23,902 | $292.0K | 0.00% | +7,686+47.4% | Added |
| Goldman Sachs Group Inc | 15,864 | $194.0K | 0.00% | −2,070−11.5% | Reduced |
| MetLife Investment Management | 10,614 | $129.6K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 9,242 | $113.0K | 0.00% | −1,356−12.8% | Reduced |
| New York State Common Retirement Fund | 8,013 | $98.0K | 0.00% | −7,508−48.4% | Reduced |
| American International Group, Inc. | 8,032 | $98.0K | 0.00% | −781−8.9% | Reduced |
| California State Teachers Retirement System | 7,338 | $90.0K | 0.00% | −241−3.2% | Reduced |
| Amalgamated Bank | 2,182 | $27.0K | 0.00% | +254+13.2% | Added |
| Citigroup Inc | 2,151 | $26.0K | 0.00% | +301+16.3% | Added |
| Tower Research Capital LLC (TRC) | 1,964 | $24.0K | 0.00% | +722+58.1% | Added |
| Legal & General Group Plc | 1,440 | $18.0K | 0.00% | −260−15.3% | Reduced |
| Metropolitan Life Insurance Co | 1,382 | $16.9K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,014 | $12.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 860 | $11.0K | 0.00% | −2,088−70.8% | Reduced |
| Royal Bank of Canada | 97 | $1.00K | 0.00% | −995−91.1% | Reduced |
| Daiwa Securities Group Inc. | 121 | $1.00K | 0.00% | 00.0% | Unchanged |
| Crewe Advisors LLC | 115 | $1.00K | 0.00% | +115 | New |
| Credit Suisse AG | 17 | $0 | 0.00% | +17 | New |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −11,480−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −4,742−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |